ATVB:改良柑橘果胶治疗血管硬化

2013-05-06 Beyond 生物谷

2012年11月23日 -- 根据美国疾病预防控制中心,今年以来,2.5万人心血管疾病杀了近。随着时间的推移,炎症反应,胶原蛋白沉积和疤痕组织形成导致血管变硬,这个过程被称为血管纤维化。虽然研究人员已经证实激素醛固酮在这个过程中起到了重要作用,但其中机制知之甚少。 现在,一项发表在美国心脏协会Arteriosclerosis, Thrombosis, and Vascular Biol

2012年11月23日 -- 根据美国疾病预防控制中心,今年以来,2.5万人心血管疾病杀了近。随着时间的推移,炎症反应,胶原蛋白沉积和疤痕组织形成导致血管变硬,这个过程被称为血管纤维化。虽然研究人员已经证实激素醛固酮在这个过程中起到了重要作用,但其中机制知之甚少。

现在,一项发表在美国心脏协会Arteriosclerosis, Thrombosis, and Vascular Biology杂志上研究给心血管疾病带来了新的见解。该研究阐明了醛固酮和半乳糖凝集素-3联合如何通过炎症反应、纤维化和胶原沉积过程,共同促进血管重构和充血性心脏衰竭。

研究结果表明,半乳糖凝集素-3对炎症和纤维化反应是必需的,这提示半乳糖凝集素-3在血管纤维化过程中起到关键作用。同样重要的是,研究证明,改良柑橘果胶(MCP),一种来源于柑橘果皮精华的制剂,可以结合半乳糖凝集素-3,控制醛固酮诱导半乳糖凝集素-3水平升高。

果胶是-种复杂的碳水化合物,存在于所有水果和蔬菜的细胞壁中。通常用作果酱和果冻产品的黏合剂。血清中半乳糖凝集素-3与心脏衰竭和转移性肿瘤的高死亡率存在密切联系。研究证实了改良柑橘果胶能减缓肿瘤的进展和转移,阻断炎症反应,有助于防止纤维化。

硬化相关的拓展阅读:

 

Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

Objective—Aldosterone (Aldo) is involved in arterial stiffness and heart failure, but the mechanisms have remained unclear. Galectin-3 (Gal-3), a β-galactoside-binding lectin, plays an important role in inflammation, fibrosis, and heart failure. We investigated here whether Gal-3 is involved in Aldo-induced vascular fibrosis.

Methods and Results—In rat vascular smooth muscle cells Gal-3 overexpression enhanced specifically collagen type I synthesis. Moreover Gal-3 inhibition by modified citrus pectin or small interfering RNA blocked Aldo-induced collagen type I synthesis. Rats were treated with Aldo-salt combined with spironolactone or modified citrus pectin for 3 weeks. Hypertensive Aldo-treated rats presented vascular hypertrophy, inflammation, fibrosis, and increased aortic Gal-3 expression. Spironolactone or modified citrus pectin treatment reversed all the above effects. Wild-type and Gal-3 knock-out mice were treated with Aldo for 6 hours or 3 weeks. Aldo increased aortic Gal-3 expression, inflammation, and collagen type I in wild-type mice at both the short- and the long-term, whereas no changes occurred in Gal-3 knock-out mice.

Conclusion—Our data indicate that Gal-3 is required for inflammatory and fibrotic responses to Aldo in vascular smooth muscle cells in vitro and in vivo, suggesting a key role for Gal-3 in vascular fibrosis.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1691256, encodeId=60101691256ff, content=<a href='/topic/show?id=378089e311a' target=_blank style='color:#2F92EE;'>#血管硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89731, encryptionId=378089e311a, topicName=血管硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae529209097, createdName=jiyangfei, createdTime=Thu Oct 31 20:56:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977926, encodeId=71d419e7926fc, content=<a href='/topic/show?id=20411e958de' target=_blank style='color:#2F92EE;'>#TVB#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17958, encryptionId=20411e958de, topicName=TVB)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a5a149, createdName=gongliu, createdTime=Fri Jul 12 10:56:00 CST 2013, time=2013-07-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1691256, encodeId=60101691256ff, content=<a href='/topic/show?id=378089e311a' target=_blank style='color:#2F92EE;'>#血管硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89731, encryptionId=378089e311a, topicName=血管硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae529209097, createdName=jiyangfei, createdTime=Thu Oct 31 20:56:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977926, encodeId=71d419e7926fc, content=<a href='/topic/show?id=20411e958de' target=_blank style='color:#2F92EE;'>#TVB#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17958, encryptionId=20411e958de, topicName=TVB)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a5a149, createdName=gongliu, createdTime=Fri Jul 12 10:56:00 CST 2013, time=2013-07-12, status=1, ipAttribution=)]
    2013-07-12 gongliu